logo-loader

OncoSec to present at 2 investor conferences this month

Published: 19:58 06 Sep 2011 BST

no_picture_pai

OncoSec Medical (OTCBB:ONCS), which is developing its advanced-stage electro-oncology therapies to treat solid tumor cancers, announced today that its president and CEO, Punit Dhillon, will be presenting a corporate overview at two upcoming investor conferences.

The first is the Rodman & Renshaw Global Healthcare Conference in New York City, to be held from September 11 to 13 at the The Waldorf Astoria. OncoSec's presentation is scheduled for September 12 at 3:40pm ET, with a live and archived webcast to be accessible on the company's website at www.oncosec.com.

The second event will be the ProActive Investors Investor Forum in New York City on September 15, at the Intercontinental New York Barclay Hotel. OncoSec will be presenting at 6:00pm ET.

OncoSec's therapies, currently in phase two trials, combine its proprietary electroporation delivery technology with a chemotherapeutic or DNA-based immunotherapeutics. Targeted local delivery of these agents is designed to selectively destroy cancerous tumors while sparing healthy normal tissue, resulting in improved outcomes.

Caledonia Mining tackles 2023 challenges with optimism for 2024 as it...

Caledonia Mining Corporation PLC (AIM:CMCL, NYSE-A:CMCL) chief executive Mark Learmonth tells Proactive's Stephen Gunnion the company faced a challenging 2023, primarily due to poor production in the first half of the year at its core asset, the Blanket Mine in Zimbabwe, and an underperformance...

1 hour, 13 minutes ago